Active Ingredient: MIRDAMETINIB
Proprietary Name: GOMEKLI
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 2MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N219389
Product Number: 002
Approval Date: Feb 11, 2025
Applicant Holder Full Name: SPRINGWORKS THERAPEUTICS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
